All Programs

Use the tool below to view all available Series

Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
MinuteCE®
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
MinuteCE®
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making  
0.50 credits 4 episodes
- James M. Cleary, MD, PhD
0.50 credits 4 episodes
From Resistance to Response: Evolving Strategies in MDD Management
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
1.00 credit
- Joseph F. Goldberg, MD
1.00 credit
Applying Perioperative ICIs in Clinical Practice
Applying Perioperative ICIs in Clinical Practice
MinuteCE®
Applying Perioperative ICIs in Clinical Practice
0.75 program credits
- Douglas Adkins, MD
0.75 program credits
Managing Immune-Related Adverse Events in the Perioperative Setting
Managing Immune-Related Adverse Events in the Perioperative Setting
MinuteCE®
Managing Immune-Related Adverse Events in the Perioperative Setting
0.75 program credits
- Douglas Adkins, MD
0.75 program credits
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
MinuteCE®
Rationale for Combining Radiation and Immunotherapy in Resectable Locally Advanced HNSCC
0.75 program credits
- Nancy Lee, MD, FASTRO
0.75 program credits
Emerging Directions in Menin-Directed AML Therapy 
Emerging Directions in Menin-Directed AML Therapy 
MinuteCE®
Emerging Directions in Menin-Directed AML Therapy 
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit
MinuteCE®
Breaking Barriers in AML: Risk Stratification, Molecular Profiling, and Novel Menin-Directed Treatment Options
1.00 credit 10 episodes
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 credit 10 episodes
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
MinuteCE®
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit
Managing Adverse Events Associated With Menin Inhibitors 
Managing Adverse Events Associated With Menin Inhibitors 
MinuteCE®
Managing Adverse Events Associated With Menin Inhibitors 
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
MinuteCE®
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit
Stratifying Risk to Guide Therapy in R/R AML 
Stratifying Risk to Guide Therapy in R/R AML 
MinuteCE®
Stratifying Risk to Guide Therapy in R/R AML 
1.00 program credit
- Ghayas Issa, MD
- Amir Fathi, MD
1.00 program credit
Integrating Palliative Care in Pulmonary Hypertension
Integrating Palliative Care in Pulmonary Hypertension
MinuteCE®
Integrating Palliative Care in Pulmonary Hypertension
1.00 program credit
- Martha Kingman, DNP, FNP-C
1.00 program credit
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
MinuteCE®
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
1.00 program credit
- H. James Ford, MD
1.00 program credit
What Challenges and Triumphs Do Patients Face While Living With PAH?
What Challenges and Triumphs Do Patients Face While Living With PAH?
MinuteCE®
What Challenges and Triumphs Do Patients Face While Living With PAH?
1.00 program credit
- H. James Ford, MD
1.00 program credit

All Programs

Popular

Title

Share on ReachMD